(Q35555966)
Statements
Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol (English)
F Atzeni
F Buttgereit
M Carrabba
11 February 2005